Literature DB >> 7713758

Improved detection of DNA aneuploidy in primary breast cancer using quantitative DNA image analysis in combination with fluorescent in situ hybridization technique.

B Verdoodt1, P Castelain, C Bourgain, M Kirsch-Volders.   

Abstract

To obtain more information about the relationship between numerical aberrations of chromosome 1 and the overall DNA content of breast cancer cells, fluorescent in situ hybridization with a pericentromeric probe for this chromosome and image analysis based densitometry were carried out on imprints of benign (15 cases, mainly fibroadenomas) and malignant breast disease (31 invasive ductal carcinomas out of 45 cases). The most pronounced aneuploidy was observed in invasive ductal and lobular carcinoma cases both by in situ hybridization and DNA content (76.7 and 75.0% were aneuploid). The frequency of cells with two spots for chromosome 1 was 48.3 and 51.5%, respectively, as compared to 80.3% in control lymphocytes. There was a weak overall correlation (r2 = 0.83) between DNA content and copy number of chromosome 1 in the malignant samples, although some of the DNA diploid/near diploid carcinomas showed a marked aneusomy for this chromosome. Also, some aberrations were present in the benign breast disease samples. Classification of cases by a linear discriminant analysis was most accurate when both techniques were combined (77% of cases correctly classified, according to anatomo-pathological diagnosis). The variables which received the highest weight in the linear discriminant function are the percentage DNA-diploid cells and the fraction of cells with two spots for chromosome 1. The sensitivity and sources of error of both techniques is considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713758     DOI: 10.1007/bf00164175

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  27 in total

1.  Interphase cytogenetics of brain tumors.

Authors:  E P Arnoldus; I A Noordermeer; A C Peters; J H Voormolen; G T Bots; A K Raap; M van der Ploeg
Journal:  Genes Chromosomes Cancer       Date:  1991-03       Impact factor: 5.006

2.  Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

Authors:  B Dutrillaux; M Gerbault-Seureau; Y Remvikos; B Zafrani; M Prieur
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

Review 3.  Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma.

Authors:  U G Falkmer
Journal:  Hum Pathol       Date:  1992-04       Impact factor: 3.466

4.  The prognostic significance of ploidy analysis in operable breast cancer.

Authors:  S Sharma; M C Mishra; B M Kapur; K Verma; I Nath
Journal:  Cancer       Date:  1991-12-15       Impact factor: 6.860

5.  Cloning of human satellite III DNA: different components are on different chromosomes.

Authors:  H J Cooke; J Hindley
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

6.  An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.

Authors:  A Longin; B Fontanière; V Pinzani; G Catimel; C Souchier; M Clavel; F Chauvin
Journal:  Pathol Res Pract       Date:  1992-06       Impact factor: 3.250

7.  Modification of tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei.

Authors:  R Kiss; P Gasperin; A Verhest; J L Pasteels
Journal:  Mod Pathol       Date:  1992-11       Impact factor: 7.842

8.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

9.  Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.

Authors:  P J Poddighe; F C Ramaekers; A W Smeets; G P Vooijs; A H Hopman
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

10.  Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.

Authors:  O Stål; J Carstensen; T Hatschek; B Nordenskjöld
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.